Search research articles
Contact Us
Filters
Showing results (81-90 of 119) with videos related to
Page
of 12
Sort By:
Frontiers in Immunology
|
August 8, 2018
Secreted Phospholipases A<sub>2</sub> in Hereditary Angioedema With C1-Inhibitor Deficiency
Stefania Loffredo, Anne Lise Ferrara, Maria Bova, et al.
Frontiers in Immunology
|
January 28, 2026
Classification of angioedema types using decision tree modeling
Felix Aulenbacher, Annika Gutsche, Henriette Farkas, et al.
Clinical and Translational Allergy
|
September 25, 2023
Evaluation of patient-reported outcome measures for on-demand treatment of hereditary angioedema attacks and design of KONFIDENT, a phase 3 trial of sebetralstat
Danny M Cohn, Emel Aygören-Pürsün, Jonathan A Bernstein, et al.
The Journal of Allergy and Clinical Immunology
|
August 8, 2017
Cleaved kininogen as a biomarker for bradykinin release in hereditary angioedema
Zonne L M Hofman, Steven de Maat, Chiara Suffritti, et al.
Allergy
|
December 21, 2019
Impaired control of the contact system in hereditary angioedema with normal C1-inhibitor
Maria Bova, Chiara Suffritti, Valeria Bafunno, et al.
Journal of Clinical Medicine
|
October 29, 2020
Deciphering the Genetics of Primary Angioedema with Normal Levels of C1 Inhibitor
Gedeon Loules, Faidra Parsopoulou, Maria Zamanakou, et al.
Health Psychology Open
|
December 21, 2020
The experience of living with a chronic disease in pediatrics from the mothers' narratives: The Clinical Interview on Parental Sense of Grip on the Disease
Livia Savarese, Maria Francesca Freda, Raffaele De Luca Picione, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
August 23, 2019
Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema
Anna Valerieva, Maria Staevska, Milos Jesenak, et al.
Revista Alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
|
October 2, 2025
[Effectiveness and safety of Lanadelumab according to disease activity: pooled analysis of EMPOWER/ENABLE]
Inmaculada Martinez-Saguer, Andrea Zanichelli, Emel Aygören-Pürsün, et al.
Orphanet Journal of Rare Diseases
|
July 15, 2018
Emotional processes and stress in children affected by hereditary angioedema with C1-inhibitor deficiency: a multicenter, prospective study
Livia Savarese, Maria Bova, Raffaella De Falco, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 119) with videos related to
Sort By:
Page
of 12
Frontiers in Immunology
|
August 8, 2018
Secreted Phospholipases A<sub>2</sub> in Hereditary Angioedema With C1-Inhibitor Deficiency
Stefania Loffredo, Anne Lise Ferrara, Maria Bova, et al.
Frontiers in Immunology
|
January 28, 2026
Classification of angioedema types using decision tree modeling
Felix Aulenbacher, Annika Gutsche, Henriette Farkas, et al.
Clinical and Translational Allergy
|
September 25, 2023
Evaluation of patient-reported outcome measures for on-demand treatment of hereditary angioedema attacks and design of KONFIDENT, a phase 3 trial of sebetralstat
Danny M Cohn, Emel Aygören-Pürsün, Jonathan A Bernstein, et al.
The Journal of Allergy and Clinical Immunology
|
August 8, 2017
Cleaved kininogen as a biomarker for bradykinin release in hereditary angioedema
Zonne L M Hofman, Steven de Maat, Chiara Suffritti, et al.
Allergy
|
December 21, 2019
Impaired control of the contact system in hereditary angioedema with normal C1-inhibitor
Maria Bova, Chiara Suffritti, Valeria Bafunno, et al.
Journal of Clinical Medicine
|
October 29, 2020
Deciphering the Genetics of Primary Angioedema with Normal Levels of C1 Inhibitor
Gedeon Loules, Faidra Parsopoulou, Maria Zamanakou, et al.
Health Psychology Open
|
December 21, 2020
The experience of living with a chronic disease in pediatrics from the mothers' narratives: The Clinical Interview on Parental Sense of Grip on the Disease
Livia Savarese, Maria Francesca Freda, Raffaele De Luca Picione, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
August 23, 2019
Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema
Anna Valerieva, Maria Staevska, Milos Jesenak, et al.
Revista Alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
|
October 2, 2025
[Effectiveness and safety of Lanadelumab according to disease activity: pooled analysis of EMPOWER/ENABLE]
Inmaculada Martinez-Saguer, Andrea Zanichelli, Emel Aygören-Pürsün, et al.
Orphanet Journal of Rare Diseases
|
July 15, 2018
Emotional processes and stress in children affected by hereditary angioedema with C1-inhibitor deficiency: a multicenter, prospective study
Livia Savarese, Maria Bova, Raffaella De Falco, et al.
Page
of 12